View webinar on drug-resistant gonorrhea
The Centers for Disease Control and Prevention (CDC) has a free webinar of its recent Public Health Grand Rounds, "The Growing Threat of Multidrug-Resistant Gonorrhea," available on its web site.
This session of grand rounds explores the development of antibiotic resistance in Neisseria gonorrhoeae. Multidrug resistance is a public health concern because the current U.S. gonorrhea control strategy relies on effective antibiotic therapy.
Topics include Neisseria gonorrhoeae infections and antimicrobial treatment, presented by Edward Hook III, MD, professor of medicine and epidemiology at University of Alabama, Birmingham; the molecular basis of resistance and importance of the laboratory in detection of resistance, presented by William Shafer, PhD, professor of Microbiology and Immunology at Emory University in Atlanta; tools to combat multidrug resistance, presented by Carolyn Deal, PhD, chief of the Sexually Transmitted Diseases Branch at the National Institute of Allergy and Infectious Diseases at the National Institutes of Health, Bethesda, MD; and what public health can do now and in the future, presented by Robert Kirkcaldy, MD, MPH, medical officer at the CDC's National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention.
To access the webinar, go to http://1.usa.gov/JXR8DI. Links are available to watch the webinar on YouTube or as a Windows Media File video. The presentations also are available as a PDF.
The Centers for Disease Control and Prevention (CDC) has a free webinar of its recent Public Health Grand Rounds, "The Growing Threat of Multidrug-Resistant Gonorrhea, available on its web site.You have reached your article limit for the month. Subscribe now to access this article plus other member-only content.
- Award-winning Medical Content
- Latest Advances & Development in Medicine
- Unbiased Content